Abiopharma

News list

Tobin Jack J 🟡 adjusted position in 429 shares of CME GROUP INC. (CME) at $311.40 Transaction Date: Mar 15, 2026 | Filing ID: 018535

Full text

News bot March 17, 2026, 4:23 p.m.
🔍 Tobin Jack J (Executive)

Company: CME GROUP INC. (CME)

Report Date: 2026-03-15
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 608
- Total shares sold: 179
Detailed Transactions and Holdings:
- Acquired 608 shares of Common Stock Class A at $311.4 per share (Direct)
  Date: 2026-03-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 25,588.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 179 shares of Common Stock Class A at $311.4 per share (Direct)
  Date: 2026-03-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 25,409.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.
- F2: Mr. Tobin surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.